DK2219652T3 - Phospholipidsammensætninger og anvendelser heraf - Google Patents
Phospholipidsammensætninger og anvendelser herafInfo
- Publication number
- DK2219652T3 DK2219652T3 DK08852865.8T DK08852865T DK2219652T3 DK 2219652 T3 DK2219652 T3 DK 2219652T3 DK 08852865 T DK08852865 T DK 08852865T DK 2219652 T3 DK2219652 T3 DK 2219652T3
- Authority
- DK
- Denmark
- Prior art keywords
- lipids
- lrh
- administration
- blood glucose
- glucose levels
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000003904 phospholipids Chemical class 0.000 title abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 102100022669 Nuclear receptor subfamily 5 group A member 2 Human genes 0.000 abstract 2
- 101710105538 Nuclear receptor subfamily 5 group A member 2 Proteins 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98850507P | 2007-11-16 | 2007-11-16 | |
| PCT/US2008/012846 WO2009067182A2 (en) | 2007-11-16 | 2008-11-17 | Phospholipid compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2219652T3 true DK2219652T3 (da) | 2012-08-06 |
Family
ID=40668049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08852865.8T DK2219652T3 (da) | 2007-11-16 | 2008-11-17 | Phospholipidsammensætninger og anvendelser heraf |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8410085B2 (da) |
| EP (1) | EP2219652B1 (da) |
| AT (1) | ATE554775T1 (da) |
| AU (1) | AU2008326800A1 (da) |
| CA (1) | CA2705530A1 (da) |
| DK (1) | DK2219652T3 (da) |
| WO (1) | WO2009067182A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0915523D0 (en) | 2009-09-07 | 2009-10-07 | Genome Res Ltd | Cells and methods for obtaining them |
| EP2598125A2 (en) * | 2010-05-20 | 2013-06-05 | Fundación Pública Andaluza Progreso Y Salud | Novel methods for preventing or treating diabetes |
| US9512406B2 (en) | 2013-12-20 | 2016-12-06 | The J. David Gladstone Institute, a testamentary trust established under the Will of J. David Gladstone | Generating hepatocytes |
| KR20180116275A (ko) | 2016-02-22 | 2018-10-24 | 노파르티스 아게 | Fxr 효능제를 사용하는 방법 |
| KR101865562B1 (ko) * | 2017-11-03 | 2018-06-08 | 주식회사 펜믹스 | 포스포콜린 유도체를 포함하는 지방분해 조성물 |
| WO2019244137A1 (en) * | 2018-06-22 | 2019-12-26 | Fonterra Co-Operative Group Limited | Use of polar lipids to treat or prevent gestational diabetes mellitus |
| CN115364111B (zh) * | 2021-05-17 | 2024-04-02 | 中国医学科学院基础医学研究所 | 甘油磷脂类化合物在治疗肿瘤中的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5910304A (en) | 1982-12-13 | 1999-06-08 | Texas A&M University System | Low-dose oral administration of interferons |
| CA1320905C (en) | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
| WO1997039759A2 (en) | 1996-04-24 | 1997-10-30 | Brigham And Women's Hospital | Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder |
| US6036949A (en) | 1998-03-05 | 2000-03-14 | Amarillo Biosciences, Inc. | Treatment of fibromyalgia with low doses of interferon |
| US6537806B1 (en) | 1998-06-02 | 2003-03-25 | University Of Washington | Compositions and methods for treating diabetes |
| US20030040505A1 (en) | 2000-03-31 | 2003-02-27 | The Regents Of The University Of California | Synthetic phospholipids to ameliorate atherosclerosis and other inflammatory conditions |
| GB0014437D0 (en) * | 2000-06-14 | 2000-08-09 | Porter William L | Immune response stimulation |
| CA2501601C (en) * | 2002-10-25 | 2008-12-30 | Seymour J. Kurtz | Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x using small unilamellar vesicles |
| WO2004108140A1 (en) * | 2003-06-05 | 2004-12-16 | Doosan Corporation | Composition for inhibiting differentiation or growth of fat cells |
| JP2007510659A (ja) | 2003-11-05 | 2007-04-26 | シェーリング コーポレイション | 脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置 |
| US20050255154A1 (en) * | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
| EP1965828A2 (en) * | 2005-12-02 | 2008-09-10 | Nastech Pharmaceutical Company Inc. | Pharmaceutical formulation for increased epithelial permeability of glucose-regulating peptide |
-
2008
- 2008-11-17 AU AU2008326800A patent/AU2008326800A1/en not_active Abandoned
- 2008-11-17 US US12/742,879 patent/US8410085B2/en not_active Expired - Fee Related
- 2008-11-17 CA CA2705530A patent/CA2705530A1/en not_active Abandoned
- 2008-11-17 AT AT08852865T patent/ATE554775T1/de active
- 2008-11-17 DK DK08852865.8T patent/DK2219652T3/da active
- 2008-11-17 EP EP08852865A patent/EP2219652B1/en not_active Not-in-force
- 2008-11-17 WO PCT/US2008/012846 patent/WO2009067182A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009067182A2 (en) | 2009-05-28 |
| WO2009067182A3 (en) | 2009-07-23 |
| EP2219652A4 (en) | 2010-11-10 |
| US20100331281A1 (en) | 2010-12-30 |
| AU2008326800A1 (en) | 2009-05-28 |
| US8410085B2 (en) | 2013-04-02 |
| EP2219652B1 (en) | 2012-04-25 |
| ATE554775T1 (de) | 2012-05-15 |
| EP2219652A2 (en) | 2010-08-25 |
| CA2705530A1 (en) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Izzo et al. | The role of oxidative stress in cardiovascular aging and cardiovascular diseases | |
| ATE554775T1 (de) | Phospholipid-zusammensetzungen und ihre verwendungen | |
| JP2007521835A5 (da) | ||
| AU2018253580A1 (en) | Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level | |
| WO2010129138A3 (en) | Phosphorylated and phosphonated pyrone analogs for therapeutic treatment | |
| WO2008027420A3 (en) | Implantable devices for producing insulin | |
| Cavalcanti et al. | Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation | |
| EA201300550A1 (ru) | Фармацевтическая композиция, способы лечения и их применение | |
| NO20092150L (no) | Fremgangsmater for behandling av hyperkolesterolemi | |
| PE20050255A1 (es) | Nuevas cianotiazolidas y procedimiento para su preparacion como medicamentos | |
| EA201200939A1 (ru) | Липиды, липидные композиции и способы их применения | |
| WO2011014661A3 (en) | Liver x receptor agonists | |
| CY1118934T1 (el) | Παρασκευη ενεργης ακρως φωσφορυλιωμενης ανθρωπινης ν-ακετυλογαλακτοζαμινης-6-σουλφατασης και χρησεις αυτης | |
| JP2016517888A5 (da) | ||
| Okerblom et al. | Human-like Cmah inactivation in mice increases running endurance and decreases muscle fatigability: implications for human evolution | |
| HK1209633A1 (en) | Compositions and methods for treating diabetes | |
| EA201190209A1 (ru) | Соединения для лечения метаболических расстройств | |
| WO2009120919A3 (en) | Fenofibrate dosage forms | |
| WO2008070311A3 (en) | Gene expression profiling of parkinson's disease | |
| EA201391063A1 (ru) | Аполипопротеин a-iv в качестве антидиабетического пептида | |
| MX2009009171A (es) | Administracion de acido 3,5-diyodotiropropionico para estimular perdida de peso y/o disminuir niveles de trigliceridos y/o para tratar sindrome metabolico. | |
| MX2009004295A (es) | Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa. | |
| EP1968561B8 (en) | Treatment of diabetic nephropathy | |
| WO2009102366A3 (en) | Expression of orphan gpr64 in inflammatory diseases | |
| WO2007056236A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intravenously |